Inactive Instrument
InspireMD Inc Stock NYSE
Stocks
US45779A5074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 33.72M 29.57M 27.26M 25.52M 47.85M 3.18B 48.84M 328M 127M 1.57B 127M 124M 5.45B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 33.72M 29.57M 27.26M 25.52M 47.85M 3.18B 48.84M 328M 127M 1.57B 127M 124M 5.45B | EV / Sales 2026 * |
3.25x | EV / Sales 2027 * | 1.54x |
| Free-Float |
80.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: InspireMD Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 62 | 2019-12-31 |
Michael Lawless
DFI | Director of Finance/CFO | 58 | 2025-06-24 |
Shany Barel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Stuka
CHM | Chairman | 71 | 2017-06-01 |
Michael Berman
BRD | Director/Board Member | 68 | 2013-02-06 |
Marvin Slosman
BRD | Director/Board Member | 62 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.25% | +8.09% | -15.46% | +10.80% | 128B | |
| -0.13% | +2.11% | +2.16% | -8.75% | 12.77B | |
| +1.30% | +10.51% | +42.40% | +105.32% | 8.48B | |
| -3.88% | -6.41% | -50.35% | -73.01% | 3.79B | |
| -0.38% | -0.97% | +17.82% | +35.82% | 2.52B | |
| -9.06% | +4.50% | +217.06% | +149.44% | 1.55B | |
| -8.75% | -13.25% | -26.08% | -26.91% | 1.53B | |
| -2.80% | -3.48% | -1.60% | -23.46% | 1.53B | |
| Average | -2.31% | -0.05% | +23.24% | +21.16% | 19.96B | |
| Weighted average by Cap. | +3.95% | +6.82% | -8.99% | +13.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.38M 9.1M 8.39M 7.85M 14.72M 979M 15.03M 101M 39M 484M 38.96M 38.11M 1.68B | 21.92M 19.22M 17.71M 16.58M 31.09M 2.07B 31.74M 213M 82.38M 1.02B 82.29M 80.5M 3.54B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
